1 – 10 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial
- 2016
- PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer
- Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion : analysis of genito-urinary and rectal toxicity
- Cost evaluations of radiotherapy: what do we know? : an ESTRO-HERO analysis
- How many new cancer patients in Europe will require radiotherapy by 2025? : an ESTRO-HERO analysis
- 2015
- 2-year cosmetic outcome of large breasted women randomized between prone and supine whole-breast irradiation (WBI)
- Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer
- The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis
- Whole breast radiotherapy in prone and supine position: what treatment technique to choose
- Prone breast irradiation: from indirect to direct tumor bed localization